Real-world clinical effectiveness and safety of vedolizumab and anti-tumor necrosis factor alpha treatment in ulcerative colitis and Crohn ’s disease patients: a German retrospective chart review

Real-world comparisons of biologic treatment outcomes for ulcerative colitis (UC) or Crohn ’s disease (CD) patients are limited. We sought to evaluate the real-world effectiveness of vedolizumab (VDZ) and anti-...

Source: BMC Gastroenterology - July 8, 2020 Category: Gastroenterology Authors: Ulf Helwig, Michael Mross, Stefan Schubert, Heinz Hartmann, Alina Brandes, Dara Stein, Christian Kempf, Jana Knop, Sarah Campbell-Hill and Robert Ehehalt Tags: Research article Source Type: research